Investigating Generic Drugs: Mending the Tattered Safety Net of the FDA

Low-quality generics are being sold at U.S. pharmacies, despite the FDA’s best efforts. In this webinar, experts reveal why the system is failing and the steps needed to drive real change in the generic drug marketplace.

Featuring

– Peter Baker, President, Live Oak Quality Assurance and Former FDA Inspector
– Rosemary Gibson, Author, China Rx: Exposing the Risks of America’s Dependence on China for Medicine
– John Gray, PhD, Dean’s Distinguished Professor, Department of Operations and Business Analytics, Ohio State University
– Suzanne Robotti, Founder and President, MedShadow Foundation